Pandemics & Infectious Diseases
Biotech- and Nanotechnology
Vaccines
Influenza
Post-Doctoral Fellowships
Spain
Wrapping Up Pandemics in New Nanomaterials
His work is at the interface of biology and chemistry, and relies on novel materials his research team is creating. They are like tiny fibers, designed with little “handles” able to grab the surface of a virus. Once it is wrapped up in these wire-like, nano-scale filaments, the virus should no longer be able to infect a cell. Being a physical block of viral activity, this method would be less susceptible to the emergence of resistant strains that is the downfall of classic treatments. What’s more, Dr. Albertazzi’s new materials, called supramolecular polymers, behave in unique and promising ways. The fiber is dynamic, its individual units assembling themselves, coming apart and changing position continuously. He has shown that this behavior allows the polymers to adapt their structure to a particular target—even a mutating virus—enhancing their ability to lock onto it.
Knowing how these fibers are interacting with the surface of the virus will be a major part of Dr. Albertazzi’s research. For this, he will rely on super-resolution microscopy to observe them and aid in the rational design of the most efficient nanomaterials to do the job. Strategies to make them non-toxic for humans and invisible to our immune system are also an essential part of the project. At a time when new approaches are critical in the fight against pandemic infectious diseases, the promise of nanomedicine and of Dr. Albertazzi’s preliminary results suggest a bright future for his very special materials.
Scientific title: Novel approaches for Pandemic Virus Targeting Using Adaptive Polymers
Lorenzo
ALBERTAZZI
Institution
Institute for Bioengineering of Catalonia
Country
Spain
Nationality
Italian
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Drug Delivery
Biotech- and Nanotechnology
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more
Laurence
SABATIER
Institut du médicament de Strasbourg
Pandemics & Infectious Diseases
Zoonose & Vector Borne Diseases
Climate Adaptation & Resilience
Global Warming
Public Health & Health Policy
AXA Project
United Kingdom
New Observatory on Dengue Outbreaks
Vector-borne diseases – human illnesses caused by parasites, viruses and bacteria transmitted by living organisms such as mosquitoes, ticks, and... Read more
Oliver
BRADY